Company Filing History:
Years Active: 2022
Title: Keunhee Oh: Innovator in Antibody Development
Introduction
Keunhee Oh is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents to his name, his work is paving the way for advancements in the treatment of autoimmune diseases and cancer.
Latest Patents
Keunhee Oh's latest patents include the following innovations:
1. **Anti-VISTA antibody and use thereof** - This invention relates to an anti-VISTA antibody or an antigen-binding fragment thereof. It includes a nucleic acid coding for the antibody, a vector carrying the nucleic acid, and a cell transformed with the vector. The invention also outlines a method for preparing the antibody and a composition for the prevention or treatment of autoimmune diseases, which comprises the same antibody. Additionally, it describes a composition for concurrent administration in combination with a PD-1 antibody or PD-L1 antibody.
2. **Anti-PD-L1 antibody and use thereof** - This patent discloses an anti-PD-L1 antibody or an antigen-binding fragment thereof. It includes a nucleic acid encoding the antibody, a vector containing the nucleic acid, and a cell transformed with the vector. The invention also details a method for producing the antibody and a pharmaceutical composition for preventing or treating cancer that contains the same. Furthermore, it describes a composition for co-administration with an antibody other than one binding to PD-L1.
Career Highlights
Keunhee Oh is currently associated with Pharmabcine Inc., where he continues to innovate in the field of antibody research. His work is instrumental in developing new therapeutic options for patients suffering from various diseases.
Collaborations
Keunhee Oh collaborates with notable colleagues, including Sang Soon Byun and Sungho Ahn. Their combined expertise enhances the research and development efforts at Pharmabcine Inc.
Conclusion
Keunhee Oh's contributions to antibody development are significant and impactful. His innovative patents are set to advance the treatment landscape for autoimmune diseases and cancer. His ongoing work at Pharmabcine Inc. continues to inspire progress in biotechnology.